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This data article presents the ﬁrst large-scale quantitative
phosphoproteomics dataset generated to decipher the signaling
networks initiated by IL-2 and IL-15 in T-lymphocytes. Data was
collected by combining immunoprecipitation of tyrosine phos-
phorylated proteins and TiO2-based phosphopeptide enrichment
with SILAC-based quantitative mass spectrometry. We report all
the proteins and phosphotyrosine-containing peptides identiﬁed
and quantiﬁed in IL-2- and IL-15-stimulated T-lymphocytes. The
gene ontology analysis of IL-2 and IL-15 effector proteins detected
in the present work is also included. The data supplied in this
article is related to the research work entitled “Simultaneous
dissection and comparison of IL-2 and IL-15 signaling pathways by
global quantitative phosphoproteomics” [1]. All mass spectrometry
data have been deposited in the ProteomeXchange with the
identiﬁer PXD001129.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
va).
N. Osinalde et al. / Data in Brief 5 (2015) 53–5854Speciﬁcations TableSubject area Cell signaling and immunology
More speciﬁc
subject areaInterleukin signaling and quantitative phosphoproteomicsType of data Mass spectrometry (MS) data
How data was
acquiredMS data was acquired in a Q-Exactive (Thermo) mass spectrometer.Data format Raw (nraw), excel ﬁles (.xlsx)
Experimental factors Kit225 T-cells were grown in light (Arg0/Lys0), medium (Arg6/Lys4) and heavy (Arg10/Lys8) media.
Differentially SILAC-labeled T-cells were kept unstimulated, treated with IL-2 or stimulated with IL-
15, respectively prior cell lysis.Experimental
featuresAfter stimulation, cells were lysed and protein extracts derived from the three different experimental
conditions were combined and enriched in tyrosine phosphorylated proteins using two antibodies.
Immune complexes were fractionated in a SDS-PAGE and in-gel digested using trypsin. Resulting
peptides were either directly analyzed by LC-MS/MS or enriched in phosphorylated peptides using
TiO2 beads prior MS analysis.Data source location Odense, Denmark
Data accessibility All MS data presented in this article are deposited in the ProteomeXchange with the identiﬁer
PXD001129 (http://proteomecentral.proteomexchange.org/datastet/PXD001129).
List of all proteins identiﬁed in each of the two replicas performed are provided in Supplementary
material linked with this article.Value of the data The ﬁrst simultaneous dissection of the signaling pathways triggered by IL-2 and IL-15 in CD4þ T-
cells provides extensive data that allows discerning between the proteins that are regulated or not
by tyrosine phosphorylation upon cytokine stimulation. The detection of numerous cytokine-dependent and – independent tyrosine phosphorylation
events enables constructing a more precise molecular snapshot of the ongoing events on T-cells
treated with IL-2 and IL-15. The identiﬁcation of previously not reported phosphorylated tyrosine residues corresponding to
distinct proteins serves as the starting point to characterize their biological relevance.1. Data, experimental design, materials and methods
In the present work we provide the data generated to unveil the signaling pathways initiated by IL-
2 and IL-15 in T-lymphocytes [1]. We include two tables containing quantitative and qualitative
information about all the proteins and phosphotyrosine (pY)-containing peptides identiﬁed and
quantiﬁed in the pY-immune complexes isolated from IL-2- and IL-15-treated T-lymphocytes, as well
as the gene ontology analysis was performed.
To assess the signaling networks initiated downstream of IL-2/IL-2R and IL-15/IL-15R complexes in
T-lymphocytes, we followed the experimental workﬂow shown in Fig. 1. (A) Kit225 T-cells were grown in
media containing either light (0/0), medium (6/4) or heavy (10/8) version of arginine and lysine until their
proteome was completely labeled. Then, cells grown in light media were kept unstimulated and thus
served as control whereas cells grown in medium and heavy media were stimulated with IL-2 and IL-15,
respectively. After protein extraction, differentially labeled cell lysates were combined in 1:1:1 ratio.
(B) Tyrosine phosphorylated proteins were enriched using phospho-speciﬁc antibodies and (C) fractionated
on a SDS-PAGE. After protein in-gel digestion and peptide extraction, resulting peptides where either
(D) enriched in phosphopeptides using TiO2 beads prior mass spectrometry (MS) analysis or (E) directly
analyzed by a QExactive mass spectrometer. (F) Acquired raw mass spectra data were analyzed using the
MaxQuant software and further data analysis was performed using David bioinformatics tools.
Fig. 1. Experimental design of the SILAC-based quantitative proteomics/phosphoproteomics experiment.
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2.1. Cell culture conditions
The human T-cell chronic lymphocytic leukaemia-derived, IL-2 dependent Kit225 cell line [2] was
maintained in RPMI 1640 medium supplemented with 10% FBS, 1% Glutamax, 1% penicillin/streptomycin
(p/s), 1% sodium pyruvate and 16 U/ml of recombinant human IL-2 (kindly provided by AIDS Research and
Reference Reagent Program, Division of AIDS, NIAD, NIH, USA) at a density of 1106 cells/ml.
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L-Lys (Gibco-Invitrogen, Carlsbad, CA), which was supplemented with 10% dyalized serum (Gibco-
Invitrogen), 1% Glutamax, 1% p/s, 1% sodium pyruvate and distinct isotopes of L-Arginine (18 mg/ml)
and L-Lysine (730 mg/ml). Externally added amino acids included: L-Arginine (Arg0), L-Lysine (Lys0),
L-Arginine-13C6 (Arg6), L-Lysine-2H4 (Lys4), L-Arginine-13C615N4 (Arg10) and L-Lysine-13C615N2 (Lys8)
from Sigma-Aldrich. Thus, Kit225 T-cells were grown either in light (Arg0/Lys0), medium (Arg6/Lys4)
or heavy (Arg10/Lys8) media for at least ﬁve divisions prior cytokine stimulation to allow complete
labeling of their proteome.2.2. Cell stimulation and protein extraction
Kit225 T-cells were IL-2-deprived for 48 h in order to arrest the cells at the G1 phase of the cell cycle and
resemble resting T-cells before cytokine treatment. Signaling cascades were induced by adding 200 U of IL-2
or IL-15 (later one purchased from PeproTech) to Kit225 cells and incubation for a period of 5 min at 37 1C.
For SILAC experiments Kit225 cells grown in light media (Arg0/Lys0) were kept unstimulated
whereas cells grown in medium (Arg6/Lys4) and heavy media (Arg10/Lys8) were stimulated with IL-2
and IL-15, respectively, as described above.
Treatment was quenched by keeping cells on ice for 5 min and rapidly proceeding with cell lysis
using ice-cold modiﬁed RIPA buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM EDTA,
0.25% sodium deoxycholate, 1 mM sodium pervanadate, 5 mM beta-glycerophosphate, 5 mM NaF,
complete protease inhibitor cocktail (Complete tablets, Roche)). Proteins were recovered from the
supernatant of the samples after 15 min centrifugation at 13,000 rpm, 4 1C. Finally, protein
concentration was determined with the BCA assay (Pierce).2.3. Immunoprecipitation of tyrosine phosphorylated proteins
The three differentially labeled protein lysates derived from untreated, IL-2-stimulated and IL-15-
stimulated T-cells were combined in 1:1:1 ratio according to their protein concentration and
incubated with 50% slurry protein A-sepharose (GE Healthcare) for 1 h at 4 1C to eliminate proteins
that bind non-speciﬁcally to the beads. Pre-cleared protein lysates were then incubated with two
complementary anti-phosphotyrosine antibodies; for 3 h at 4 1C with agarose conjugated 4G10
(Millipore, MA, USA) and for additional 3 h with immobilized p-Tyr-100 antibody (Cell Signaling,
Beverly, MA). Eluted immune complexes were equally split and run on 2 parallel lanes of a precast
gradient NuPAGE 4–12% Bis-Tris Gel (Invitrogen) and visualized with Colloidal Blue (Invitrogen)
(Supplementary Fig. 1).2.4. In-gel digestion and peptide extraction
Gel lanes were cut into slices and subjected to in-gel reduction, alkylation and trypsin digestion basically as
previously described [3]. Brieﬂy, gel slices were discolored and dehydrated by serial incubations with 100mM
ammonium bicarbonate/100% ethanol (1/1, vol/vol) and 100% ethanol. Peptide reduction was achieved by
incubating gel slices with 10mM DTT for 45min at 56 1C, followed by dehydration and peptide alkylation
whichwas performed by incubationwith 55mMchloroacetamide for 30min at room temperature in the dark.
Subsequently, gel slices were incubated with 100% ethanol until they became white and shrink to ﬁnally
perform the protein digestion by adding trypsin (12.5 ng/ml) and incubating overnight at 37 1C. To keep gel
pieces wet during enzymatic cleavage add 30–50 ml of ammonium bicarbonate buffer on top of the gels.
Peptides were extracted from the gel by serial 10 min incubations with 100% acetonitrile (ACN) and
30% ACN/3% TFA at room temperature in a shaker. The supernatant obtained in the distinct
incubations were pooled and dried down in a vacuum centrifuge.
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Enrichment of phosphopeptides was performed as previously described [4]. Titansphere beads (5 mm
diameter) were mixed with the equilibration buffer (50mg/ml DHB in 80% ACN/1% TFA) in 1:1 (w/w) for
30min at room temperature and samples were adjusted to 60% ACN/1% TFA. 1–2 ml of equilibrated TiO2 slurry
was added to the sample and incubated for 30min at room temperature with rotation. After brief
centrifugation, supernatant was removed and TiO2 beads were transferred onto a C8 STAGE Tip where they
were washed two times is 60% ACN/1% TFA and then eluted with 215 ml 5% NH4OH followed by 215 ml
25% NH4OH/0.3% TFA.
2.6. Mass spectrometry analysis
Prior MS analysis all samples were desalted and concentrated on a C18 STAGE-tip. Peptides were
eluted with 50% ACN/1% TFA, dried down in a vacuum centrifuge and ﬁnally resuspend in 2% ACN/0.3%
TFA. Acidiﬁed peptide mixtures were separated on a 75-μm inner diameter 20-cm-long column
packed in-house with ReproSil-Pur C18-AQ 3 μm resin (Dr. Maisch GmbH). Reverse-phase
chromatography was performed with an EASY-nLC 1000 ultra-high pressure system (Thermo Fisher
Scientiﬁc), which was coupled to the Q Exactive mass spectrometer (Thermo Fisher Scientiﬁc) via a
nanoelectrospray source (Thermo Fisher Scientiﬁc). Peptides were loaded in solvent A (0.5% aceticFig. 2. Gene ontology analysis of proteins enriched in phosphotyrosine immunocomplexes isolated upon 5 min stimulation
with IL-2 and IL-15. The most representative terms corresponding to (A) biological process, (B) molecular function, (C) cellular
compartment and (D) protein domains that we found enriched within our dataset of IL-2 and IL-15 effector proteins are
represented by fold enrichment of the terms as well as by % of proteins within our dataset included in such a term.
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ﬂow rate of 250 nl/min. MS instrument was operated to automatically switch between full-scan MS
(m/z range, 300–1750; maximum injection time 120 ms; resolution 70,000 at m/z 400; target of 106
ions) and up to 10 data-dependent MS/MS scans (maximum injection time 124 ms; resolution 35,000
at m/z 400; target of 104 ions). Precursors were fragmented by higher-energy C-trap dissociation
(HCD) with normalized collision energy of 25 eV. Repeat sequencing of peptides was minimized by
excluding the selected peptide candidates for 45 s.
2.7. Data analysis
Acquired raw mass spectra data from both biological replicates were combined and processed
using the MaxQuant software v1.3.0.5. applying the parameters as previously described [5]. For
protein identiﬁcation at least two peptides, including 1 unique were required. Both razor and unique
peptides, except Phospho-STY modiﬁed peptides, were considered for protein group quantiﬁcation.
Supplementary Table 1 contains information about all identiﬁed and quantiﬁed proteins.
The biological functions, cellular localization and proteins domains overrepresented among the
proteins enriched (IL-2/Ctr and/or IL-15/Ctr ratio41.5 and statistically signiﬁcance value po0.01) in
the phosphotyrosine immunocomplexes upon cytokine stimulation were studied using The Database
for Annotation, Visualization and Integrated Discovery (DAVID) [6]. Within our dataset of IL-2 and IL-
15 effector proteins we detected that several (Fig. 2A) biological processes, (Fig. 2B) molecular
functions, (Fig. 2C) cellular compartments and (Fig. 2D) protein domains were highly enriched.
For the analysis of pY-containing peptides, 1% FDR, a minimum localization probability of 0.75 and
score difference of 5 (ClassI phosphopeptides) were demanded [7,8]. Supplementary Table 2 contains
information about all identiﬁed and quantiﬁed pY-containing ClassI and ClassII phosphopeptides.Acknowledgments
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